ITCI vs. AXSM
Compare and contrast key facts about Intra-Cellular Therapies, Inc. (ITCI) and Axsome Therapeutics, Inc. (AXSM).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ITCI or AXSM.
Correlation
The correlation between ITCI and AXSM is 0.33, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
ITCI vs. AXSM - Performance Comparison
Loading data...
Key characteristics
Fundamentals
ITCI:
$14.05B
AXSM:
$5.29B
ITCI:
-$0.73
AXSM:
-$5.77
ITCI:
0.00
AXSM:
0.00
ITCI:
20.63
AXSM:
12.25
ITCI:
12.23
AXSM:
99.51
ITCI:
$535.77M
AXSM:
$432.16M
ITCI:
$488.71M
AXSM:
$395.36M
ITCI:
-$95.53M
AXSM:
-$266.14M
Returns By Period
ITCI
N/A
N/A
N/A
N/A
N/A
N/A
N/A
AXSM
28.00%
3.68%
17.14%
41.49%
50.69%
4.98%
N/A
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
ITCI vs. AXSM — Risk-Adjusted Performance Rank
ITCI
AXSM
ITCI vs. AXSM - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Intra-Cellular Therapies, Inc. (ITCI) and Axsome Therapeutics, Inc. (AXSM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
ITCI vs. AXSM - Dividend Comparison
Neither ITCI nor AXSM has paid dividends to shareholders.
Drawdowns
ITCI vs. AXSM - Drawdown Comparison
Loading data...
Volatility
ITCI vs. AXSM - Volatility Comparison
Loading data...
Financials
ITCI vs. AXSM - Financials Comparison
This section allows you to compare key financial metrics between Intra-Cellular Therapies, Inc. and Axsome Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ITCI vs. AXSM - Profitability Comparison
ITCI - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Intra-Cellular Therapies, Inc. reported a gross profit of 178.82M and revenue of 199.22M. Therefore, the gross margin over that period was 89.8%.
AXSM - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Axsome Therapeutics, Inc. reported a gross profit of 111.67M and revenue of 121.46M. Therefore, the gross margin over that period was 91.9%.
ITCI - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Intra-Cellular Therapies, Inc. reported an operating income of -29.20M and revenue of 199.22M, resulting in an operating margin of -14.7%.
AXSM - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Axsome Therapeutics, Inc. reported an operating income of -56.98M and revenue of 121.46M, resulting in an operating margin of -46.9%.
ITCI - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Intra-Cellular Therapies, Inc. reported a net income of -16.89M and revenue of 199.22M, resulting in a net margin of -8.5%.
AXSM - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Axsome Therapeutics, Inc. reported a net income of -59.41M and revenue of 121.46M, resulting in a net margin of -48.9%.